Page last updated: 2024-08-17

cytidine monophosphate and Liver Neoplasms

cytidine monophosphate has been researched along with Liver Neoplasms in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (50.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armeanu-Ebinger, S; Dewerth, A; Eicher, C; Ellerkamp, V; Fuchs, J; Schott, S	1
Boyer, SH; Craigo, W; Erion, MD; Esterbrook, J; Gómez-Galeno, JE; Jiang, H; MacKenna, DA; Reddy, KR; Sun, Z; Ugarkar, BG	1
Miyazawa, J; Sakata, Y; Suto, K; Suto, T; Watanabe, Y; Yoshida, Y	1
Chida, N; Ono, T; Oohira, H; Sakata, Y; Suto, T; Yamada, N; Yoshida, T; Yoshida, Y	1

Trials

2 trial(s) available for cytidine monophosphate and Liver Neoplasms

Article	Year
The effect of YNK-01 (an oral prodrug of cytarabine) on hepatocellular carcinoma. Seminars in oncology, 1997, Volume: 24, Issue:2 Suppl 6 Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prodrugs; Tomography, X-Ray Computed	1997
[Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12 Topics: Administration, Oral; Aged; Anemia; Anorexia; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Thrombocytopenia	1998

Article

Year

The effect of YNK-01 (an oral prodrug of cytarabine) on hepatocellular carcinoma.

Seminars in oncology, 1997, Volume: 24, Issue:2 Suppl 6

Topics: Administration, Oral; Aged; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prodrugs; Tomography, X-Ray Computed

1997

[Late phase II study of YNK-01 (an oral prodrug of cytarabine) for hepatocellular carcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:12

Topics: Administration, Oral; Aged; Anemia; Anorexia; Antineoplastic Agents; Arabinonucleotides; Carcinoma, Hepatocellular; Cytidine Monophosphate; Drug Administration Schedule; Female; Humans; Leukopenia; Liver Neoplasms; Male; Middle Aged; Thrombocytopenia

1998

Other Studies

2 other study(ies) available for cytidine monophosphate and Liver Neoplasms

Article	Year
Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines. Pediatric surgery international, 2013, Volume: 29, Issue:2 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytidine Monophosphate; Flow Cytometry; Fluorodeoxyuridylate; Hepatoblastoma; Humans; Liver Neoplasms; Oligonucleotides; Tumor Cells, Cultured	2013
Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma. Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26 Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Bone Marrow; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Cytidine Monophosphate; Hepatocytes; Liver; Liver Neoplasms; Male; Mice; Prodrugs; Rats; Tissue Distribution	2006

Article

Year

Effect of duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) on hepatoblastoma cell lines.

Pediatric surgery international, 2013, Volume: 29, Issue:2

Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytidine Monophosphate; Flow Cytometry; Fluorodeoxyuridylate; Hepatoblastoma; Humans; Liver Neoplasms; Oligonucleotides; Tumor Cells, Cultured

2013

Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.

Journal of medicinal chemistry, 2006, Dec-28, Volume: 49, Issue:26

Topics: Animals; Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Arabinonucleotides; Bone Marrow; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Cytidine Monophosphate; Hepatocytes; Liver; Liver Neoplasms; Male; Mice; Prodrugs; Rats; Tissue Distribution

2006